Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 20368553

Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2010 May 1
First author
Escudier B

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Curr Oncol Rep. 2011 Jun;13(3):153-6. doi: 10.1007/s11912-011-0167-y.
    note
    Source null
    related pmid
    21455732
    relationship
    Comment in

Authors and identifiers

  1. name
    Escudier B
    type
    Author
  2. name
    Bellmunt J
    type
    Author
  3. name
    Négrier S
    type
    Author
  4. name
    Bajetta E
    type
    Author
  5. name
    Melichar B
    type
    Author
  6. name
    Bracarda S
    type
    Author
  7. name
    Ravaud A
    type
    Author
  8. name
    Golding S
    type
    Author
  9. name
    Jethwa S
    type
    Author
  10. name
    Sneller V
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Escudier B
    type
    Author
  2. name
    Bellmunt J
    type
    Author
  3. name
    Négrier S
    type
    Author
  4. name
    Bajetta E
    type
    Author
  5. name
    Melichar B
    type
    Author
  6. name
    Bracarda S
    type
    Author
  7. name
    Ravaud A
    type
    Author
  8. name
    Golding S
    type
    Author
  9. name
    Jethwa S
    type
    Author
  10. name
    Sneller V
    type
    Author
bibliography ids
  1. nci-bib-3ab3cf4aa1b0d91a13f099df
book metadata
content sha256
9eb10f3445e6a0c4adebebf50e1164958fa33fa1fd2f314b6b2c6df77230490d
document type
citation
dois
  1. 10.1200/JCO.2009.26.7849
electronic publication date
display
2010 Apr 5
precision
day
year
2010
evidence scope
bibliographic_metadata_only
id
pubmed:20368553
immutable id
pubmed:20368553@9eb10f3445e6a0c4adebebf50e1164958fa33fa1fd2f314b6b2c6df77230490d
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
13
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2144-50
volume
28
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Curr Oncol Rep. 2011 Jun;13(3):153-6. doi: 10.1007/s11912-011-0167-y.
    note
    Source null
    related pmid
    21455732
    relationship
    Comment in
outcomes validated
false
pmid
20368553
provenance
batch id
bce21fa556c206e375c2
provider
NCBI PubMed ESummary
record sha256
6843b1a97c26e5c9529ee48aef98d8ba21f3cb5e17cd743a61f8d2a862547789
response sha256
280642fcc56e65c443f5ee9e69c6371de9e91c70665c7390bba25595a34da323
retrieved at
2026-09-09T23:46:33.526275+00:00
publication date
display
2010 May 1
precision
day
year
2010
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/20368553/
title
Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival.

Preserved source evidence · Not medical advice